An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis.
Influence of trace elements in body metabolism and their physiological importance in various diseases have motivated their accurate and quantitative determination in biological tissues and fluids. Instrumental Neutron Activation Analysis (INAA) using short and long term irradiation has been employed to determine five minor elements (Cl, K, Na, Mg, P) and 15 trace elements (As, Br, Co, Cr, Cs, Cu, Fe, Hg, Mn, Rb, Sb, Se, Sc, Sr, and Zn) in cancerous and normal breast tissue from 30 patients of four clinical stages. Several elements show enhancement in cancerous breast tissue. Selenium shows maximum enhancement of 94.7% followed by K (81.6%), Sc (66.7%), Cu (58.2%) Na (48.5%), P (44.4%), and Zn (39.2%). Some elements, such as Fe, Cr, and Mn, are depressed by 30.8, 30.1, and 12.8%, respectively. These elements compete for binding sites in the cell, change its enzymatic activity and exert direct or indirect action on the carcinogenic process accelerating the growth of tumors. This is further evidenced by histopathological examination of cancerous cells showing poor cytological differentiation. An attempt has been made to correlate trace element concentrations of Se, Cu, Zn, Rb, Br, Hg, As, Co, Fe, Cr, and Mn and the ratios of Se/Zn, K/P, Cu/Zn, Na/K, and Se/Fe with the clinical stages of cancer. Inhibition of enzymatic activity caused by variation in trace element concentrations results in immunological breakdown of the body system.
Garg
A N
AN
Department of Chemistry, Nagpur University, India.
Singh
V
V
Weginwar
R G
RG
Sagdeo
V N
VN
D000328:Adult; D000368:Aged; D000818:Animals; D001667:Binding, Competitive; D001943:Breast Neoplasms / Q000139:chemically induced / Q000737:chemistry*; D002273:Carcinogens / Q000032:analysis; D004791:Enzyme Inhibitors; D005720:Gamma Rays; D006207:Half-Life; D006801:Humans; D008137:Longitudinal Studies; D015409:Mastectomy, Radical; D008875:Middle Aged; D009501:Neutron Activation Analysis; D012015:Reference Standards; D014018:Tissue Distribution; D014131:Trace Elements / Q000009:adverse effects / Q000032:analysis*
D002273:Carcinogens; D004791:Enzyme Inhibitors; D014131:Trace Elements